FdaApplication

ANDA 202547

Back to search

Identifiers

Properties

PropertyValue
applicant_nameORBION PHARMACEUTICALS PRIVATE LTD
application_typeANDA
approval_date2017-12-11

Products (2)

ProductActive ingredientStrengthDosage form
ARIPIPRAZOLEARIPIPRAZOLE10MGTABLET, ORALLY DISINTEGRATING;ORAL
ARIPIPRAZOLEARIPIPRAZOLE15MGTABLET, ORALLY DISINTEGRATING;ORAL

2 products